Brain Metastasis in Renal Cancer Patients: Metastatic Pattern, Tumour-associated Macrophages and Chemokine/chemoreceptor Expression

Overview

Journal Br J Cancer

Specialty Oncology

Date 2013 Dec 12

PMID 24327013

Citations 46

Authors

L Wyler

C U Napoli

B Ingold

T Sulser

M Heikenwalder

P Schraml

H Moch

Affiliations

Soon will be listed here.

Abstract

Background: The mechanisms of brain metastasis in renal cell cancer (RCC) patients are poorly understood. Chemokine and chemokine receptor expression may contribute to the predilection of RCC for brain metastasis by recruitment of monocytes/macrophages and by control or induction of vascular permeability of the blood-brain barrier.

Methods: Frequency and patterns of brain metastasis were determined in 246 patients with metastatic RCC at autopsy. Expression of CXCR4, CCL7 (MCP-3), CCR2 and CD68(+) tumour-associated macrophages (TAMs) were analysed in a separate series of 333 primary RCC and in 48 brain metastases using immunohistochemistry.

Results: Fifteen percent of 246 patients with metastasising RCC had brain metastasis. High CXCR4 expression levels were found in primary RCC and brain metastases (85.7% and 91.7%, respectively). CCR2 (52.1%) and CCL7 expression (75%) in cancer cells of brain metastases was more frequent compared with primary tumours (15.5% and 16.7%, respectively; P<0.0001 each). The density of CD68(+) TAMs was similar in primary RCC and brain metastases. However, TAMs were more frequently CCR2-positive in brain metastases than in primary RCC (P<0.001).

Conclusion: Our data demonstrate that the monocyte-specific chemokine CCL7 and its receptor CCR2 are expressed in tumour cells of RCC. We conclude that monocyte recruitment by CCR2 contributes to brain metastasis of RCC.

Citing Articles

Molecular Underpinnings of Brain Metastases.

Jacome M, Wu Q, Chen J, Mohamed Z, Mokhtari S, Pina Y Int J Mol Sci. 2025; 26(5).

PMID: 40076927 PMC: 11900073. DOI: 10.3390/ijms26052307.

Tumor-to-tumor metastasis of clear cell renal cell carcinoma to meningioma: illustrative case.

Ditzel R, Chiu L, Siblini H, Cannon H, Goel K, Pearce J J Neurosurg Case Lessons. 2025; 9(10).

PMID: 40064003 PMC: 11894273. DOI: 10.3171/CASE24670.

Hemorrhagic intramedullary spinal cord metastasis from renal cell carcinoma: a rare case 15 years after cured renal cell carcinoma. Illustrative case.

Khalil Al-Barbarawi M, Badary A, Silbermann J, Atallah O, Kinan Sultan M, Osman A J Neurosurg Case Lessons. 2024; 8(16).

PMID: 39401466 PMC: 11488368. DOI: 10.3171/CASE24349.

The power of many: Multilevel targeting of representative chemokine and metabolite GPCRs in personalized cancer therapy.

Inverso D, Tacconi C, Ranucci S, De Giovanni M Eur J Immunol. 2024; 54(12):e2350870.

PMID: 39263783 PMC: 11628915. DOI: 10.1002/eji.202350870.

Evolutionary Trend Analysis of Research on Immunotherapy for Brain Metastasis Based on Machine-Learning Scientometrics.

Hu X, Deng X, Xie J, Zhang H, Zhang H, Feng B Pharmaceuticals (Basel). 2024; 17(7).

PMID: 39065701 PMC: 11280367. DOI: 10.3390/ph17070850.

References

Gouttefangeas C, Stenzl A, Stevanovic S, Rammensee H . Immunotherapy of renal cell carcinoma. Cancer Immunol Immunother. 2006; 56(1):117-28. PMC: 11030119. DOI: 10.1007/s00262-006-0172-4. View

Mishra P, Banerjee D, Ben-Baruch A . Chemokines at the crossroads of tumor-fibroblast interactions that promote malignancy. J Leukoc Biol. 2010; 89(1):31-9. DOI: 10.1189/jlb.0310182. View

Bianchi M, Sun M, Jeldres C, Shariat S, Trinh Q, Briganti A . Distribution of metastatic sites in renal cell carcinoma: a population-based analysis. Ann Oncol. 2011; 23(4):973-80. DOI: 10.1093/annonc/mdr362. View

Salmaggi A, Maderna E, Calatozzolo C, Gaviani P, Canazza A, Milanesi I . CXCL12, CXCR4 and CXCR7 expression in brain metastases. Cancer Biol Ther. 2009; 8(17):1608-14. DOI: 10.4161/cbt.8.17.9202. View

Schouten L, Rutten J, Huveneers H, Twijnstra A . Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma. Cancer. 2002; 94(10):2698-705. DOI: 10.1002/cncr.10541. View

Wolf M, Hoos A, Bauer J, Boettcher S, Knust M, Weber A . Endothelial CCR2 signaling induced by colon carcinoma cells enables extravasation via the JAK2-Stat5 and p38MAPK pathway. Cancer Cell. 2012; 22(1):91-105. DOI: 10.1016/j.ccr.2012.05.023. View

Medioni J, Cojocarasu O, Belcaceres J, Halimi P, Oudard S . Complete cerebral response with sunitinib for metastatic renal cell carcinoma. Ann Oncol. 2007; 18(7):1282-3. DOI: 10.1093/annonc/mdm275. View

Liang Z, Wu T, Lou H, Yu X, Taichman R, Lau S . Inhibition of breast cancer metastasis by selective synthetic polypeptide against CXCR4. Cancer Res. 2004; 64(12):4302-8. DOI: 10.1158/0008-5472.CAN-03-3958. View

Yoshidome H, Kohno H, Shida T, Kimura F, Shimizu H, Ohtsuka M . Significance of monocyte chemoattractant protein-1 in angiogenesis and survival in colorectal liver metastases. Int J Oncol. 2009; 34(4):923-30. DOI: 10.3892/ijo_00000218. View

10.

Ingold B, Schraml P, Heppner F, Moch H . Homogeneous MGMT immunoreactivity correlates with an unmethylated MGMT promoter status in brain metastases of various solid tumors. PLoS One. 2009; 4(3):e4775. PMC: 2652028. DOI: 10.1371/journal.pone.0004775. View

11.

DAlterio C, Cindolo L, Portella L, Polimeno M, Consales C, Riccio A . Differential role of CD133 and CXCR4 in renal cell carcinoma. Cell Cycle. 2010; 9(22):4492-4500. DOI: 10.4161/cc.9.22.13680. View

12.

Mildner A, Schmidt H, Nitsche M, Merkler D, Hanisch U, Mack M . Microglia in the adult brain arise from Ly-6ChiCCR2+ monocytes only under defined host conditions. Nat Neurosci. 2007; 10(12):1544-53. DOI: 10.1038/nn2015. View

13.

Dahinden C, Ingold B, Wild P, Boysen G, Luu V, Montani M . Mining tissue microarray data to uncover combinations of biomarker expression patterns that improve intermediate staging and grading of clear cell renal cell cancer. Clin Cancer Res. 2009; 16(1):88-98. DOI: 10.1158/1078-0432.CCR-09-0260. View

14.

Soria G, Ofri-Shahak M, Haas I, Yaal-Hahoshen N, Leider-Trejo L, Leibovich-Rivkin T . Inflammatory mediators in breast cancer: coordinated expression of TNFα & IL-1β with CCL2 & CCL5 and effects on epithelial-to-mesenchymal transition. BMC Cancer. 2011; 11:130. PMC: 3095565. DOI: 10.1186/1471-2407-11-130. View

15.

Gahan J, Gosalbez M, Yates T, Young E, Escudero D, Chi A . Chemokine and chemokine receptor expression in kidney tumors: molecular profiling of histological subtypes and association with metastasis. J Urol. 2012; 187(3):827-33. PMC: 5221742. DOI: 10.1016/j.juro.2011.10.150. View

16.

Ingold B, Wild P, Nocito A, Amin M, Storz M, Heppner F . Renal cell carcinoma marker reliably discriminates central nervous system haemangioblastoma from brain metastases of renal cell carcinoma. Histopathology. 2008; 52(6):674-81. DOI: 10.1111/j.1365-2559.2008.03003.x. View

17.

Lee B, Lee T, Avraham S, Avraham H . Involvement of the chemokine receptor CXCR4 and its ligand stromal cell-derived factor 1alpha in breast cancer cell migration through human brain microvascular endothelial cells. Mol Cancer Res. 2004; 2(6):327-38. View

18.

Bubendorf L, Schopfer A, Wagner U, Sauter G, Moch H, Willi N . Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients. Hum Pathol. 2000; 31(5):578-83. DOI: 10.1053/hp.2000.6698. View

19.

Motzer R, Bander N, Nanus D . Renal-cell carcinoma. N Engl J Med. 1996; 335(12):865-75. DOI: 10.1056/NEJM199609193351207. View

20.

Eichler A, Chung E, Kodack D, Loeffler J, Fukumura D, Jain R . The biology of brain metastases-translation to new therapies. Nat Rev Clin Oncol. 2011; 8(6):344-56. PMC: 3259742. DOI: 10.1038/nrclinonc.2011.58. View